RBB

Dean Curry

Dean is a Principal based in RBB’s Madrid office with over ten years’ experience. He has advised clients on numerous high-profile merger and abuse of dominance cases before the European Commission and CMA, particularly in tender markets and the pharmaceutical sector.

He holds an MSc in Economics from the Barcelona Graduate School of Economics.

Selected Cases

  • Siemens/Alstom

    Merger, Global

  • Teva/Allergan

    Merger, EU

  • Teva (Copaxone)

    Alleged abuse of dominance, EU

  • Teva (Copaxone)

    Damages Litigation, Germany

  • Generics UK (Paroxetine)

    Alleged abuse of dominance, UK (CAT)

  • Sony/ATV/Sony Music

    Merger, EU

  • Metso/Outosec

    Merger, EU

  • Nordic Capital/Intrum Justitia

    Merger, EU

  • General Electric/Avio

    Merger, EU

  • Lloyd's Banking Group/Standard Life

    Litigation, UK

A global network of experienced experts

Our 230-strong, multi-lingual team, spread across 16 offices, has managed over 3,000 cases in 120+ countries, advising on more than one-third of EU Phase II cases in the last 5 years.